What Is Psychosis: Symptoms, Causes, and Treatment Overview

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice, diagnosis, or treatment.

What Is Psychosis?

Psychosis is a clinical syndrome characterized by a break from reality, involving one or more of the following: hallucinations (perceiving things without external stimuli), delusions (fixed false beliefs that are not culturally shared), and disorganized thinking or behavior. Psychosis is not a diagnosis in itself but a symptom state that can occur in numerous psychiatric and medical conditions. Globally, approximately 3% of people experience at least one episode of psychosis during their lifetime. Schizophrenia—the condition most commonly associated with psychosis—affects approximately 1% of the world population. Psychosis typically first emerges in late adolescence or early adulthood, making it a major cause of disability in young people.

Core Symptoms of Psychosis

The DSM-5 identifies the following symptom domains in psychotic disorders:

• Hallucinations: Sensory perceptions without external stimulus. Auditory hallucinations—voices, often commenting on actions or issuing commands—are most common in schizophrenia. Visual, tactile, olfactory, and gustatory hallucinations occur and may suggest specific etiologies (e.g., visual hallucinations are more common in substance-induced or medical psychosis).
• Delusions: Fixed, false beliefs firmly held despite contradictory evidence. Paranoid delusions (being persecuted, monitored, or conspired against) are most common. Others include grandiose (believing oneself to have special powers), erotomanic, somatic, and referential (believing neutral events are personally directed messages).
• Disorganized thinking: Manifests as loose associations (tangential or incoherent speech), word salad (unintelligible speech), and thought blocking. Assessed through observed speech and communication.
• Disorganized or abnormal motor behavior: Ranges from agitation to catatonia (marked decrease in responsiveness), echolalia, or bizarre postures.
• Negative symptoms: Diminished emotional expression (flat affect), alogia (poverty of speech), anhedonia, avolition (lack of motivation), and social withdrawal. Negative symptoms respond poorly to antipsychotics and are a major driver of long-term disability.

Conditions That Cause Psychosis

Neurobiological Mechanisms: The Dopamine Hypothesis

The dopamine hypothesis—first proposed in the 1960s—remains the dominant neurobiological framework for psychosis. It posits that mesolimbic dopamine hyperactivity drives positive symptoms (hallucinations, delusions) while mesocortical dopamine deficiency contributes to negative symptoms and cognitive impairment. Key evidence includes: all effective antipsychotics block D2 dopamine receptors; dopamine-releasing substances (amphetamine, cocaine) can precipitate psychosis; PET imaging shows elevated presynaptic dopamine synthesis in schizophrenia. However, the hypothesis is incomplete—glutamate system dysfunction (particularly NMDA receptor hypofunction, supported by ketamine's psychotomimetic effects) and serotonin dysregulation are also involved, explaining why clozapine (which has broader receptor activity than pure D2 blockers) remains the most effective antipsychotic.

Schizophrenia: Diagnosis and Course

Schizophrenia requires two or more characteristic symptoms (hallucinations, delusions, disorganized speech, disorganized/catatonic behavior, negative symptoms) for a significant portion of a one-month period, with continuous disturbance lasting at least 6 months. The typical clinical course involves a prodromal phase of subtle symptoms and functional decline preceding the first psychotic break, followed by an acute phase, then a residual phase in which negative symptoms and cognitive difficulties often persist. Outcomes are heterogeneous: approximately one-third of patients achieve sustained recovery, one-third have significant but manageable symptoms, and one-third have severe, treatment-resistant illness.

Genetic heritability is approximately 80%. If one identical twin has schizophrenia, the concordance rate in the co-twin is approximately 40–50%—demonstrating both strong genetic influence and the necessity of environmental triggers (cannabis use, urban upbringing, migration stress, childhood trauma, prenatal infections).

Antipsychotic Medications

Early Intervention and Recovery

Coordinated specialty care (CSC) programs—such as NAVIGATE in the US and EPPIC in Australia—that provide early intervention at the first episode of psychosis demonstrate significantly improved outcomes compared to standard care. These programs combine low-dose antipsychotics, individual resilience training (CBT for psychosis), supported employment and education, and family education. The duration of untreated psychosis (DUP)—the time between first psychotic symptoms and treatment initiation—is a strong predictor of long-term outcome; shorter DUP is consistently associated with better recovery.

Non-Pharmacological Approaches

Cognitive behavioral therapy for psychosis (CBTp) is an evidence-based adjunctive treatment that helps patients develop alternative explanations for psychotic experiences and reduce distress. Family therapy and psychoeducation significantly reduce relapse rates. Supported employment models (Individual Placement and Support, IPS) have strong evidence for improving vocational outcomes in schizophrenia, with employment rates approximately double those achieved through conventional vocational rehabilitation.